According to the latest report by IMARC Group, titled “Brachytherapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on brachytherapy market. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
The global brachytherapy market size reached US$ 821.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,052.0 Million by 2028, exhibiting a growth rate (CAGR) of 3.4% during 2023-2028.
Brachytherapy is a procedure that includes the insertion of radioactive material inside the body. It is a radiation therapy mainly used to treat cancerous cells inside the body. In the process, radioactive materials are placed inside the patient's body to deliver high radiation doses to the target areas. Brachytherapy utilizes two types of techniques, namely Low Dose Rate (LDR) and High Dose Rate (HDR). These techniques are used for the treatment of prostate cancer. It offers various benefits over traditional treatment procedures, such as lower treatment time and higher efficacy. Brachytherapy is currently backed with software solutions that enable healthcare providers to manage and schedule Brachytherapy for patients properly.
Get a Sample Copy of this Report: https://www.imarcgroup.com/brachytherapy-market/requestsample
Market Trends:
The global market is majorly driven by the increasing prevalence of cancer. In line with this, promising applications of Brachytherapy in prostate cancer treatment are significantly contributing to the market growth. Furthermore, the rising usage of the procedure in Accelerated Partial Breast Irradiation (APBI) is positively influencing the market growth. Apart from this, rapid technological developments in this field and market players' research and development investments by major players are further catalyzing the market growth. Moreover, the growing prevalence of cervical and lung cancer in advancing regions and advanced healthcare infrastructure across the globe is propelling the brachytherapy market growth. Besides, the rising adoption of minimally invasive surgeries is offering numerous opportunities for market expansion. Additionally, the leading players are opting for acquisitions of smaller players to expand their regional presence and gain a competitive edge.
Explore Full Report with Table of Contents: https://www.imarcgroup.com/brachytherapy-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Acusis
- Transcend Services
- Naunce Communications
- MModal
- iMedX Information Services
- Global Medical Transcription
- nThrive
- MTBC
- Medi-Script Plus
- Transtech Medical Solutions
Brachytherapy Market Segmentation:
Our report has categorized the market based on region, service type, technology, mode of procurement and end user.
Breakup by Service Type:
- History and Physical Report
- Discharge Summary
- Operative Note or Report
- Consultation Report
- Others (Pathology Report, Radiology Report, etc.)
Breakup by Technology:
- EMR/EHR
- PACS
- RIS
- SRT
- Others
Breakup by Mode of Procurement:
- Outsourcing
- Offshoring
- Both
Breakup by End User:
- Hospitals
- Clinics
- Clinical Laboratories
- Academic Medical Centers
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
